Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Daniel, Peter Prof. Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Graf, Robin Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kocks, Christine Dr. (1) Landthaler, Markus Prof. Dr. (1) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Mertins, Philipp Dr. (1) Popp, Oliver Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rehm, Armin Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (1) (-) Janz, Martin Dr. (8) (-) Prigione, Alessandro Prof. Dr. (1) (-) Selbach, Matthias Prof. Dr. (8) 1999 (2) 2001 (3) 2002 (3) 2003 (4) 2004 (4) 2005 (6) (-) 2006 (6) 2007 (3) 2008 (5) 2009 (9) 2010 (4) 2011 (11) 2012 (6) 2013 (6) 2014 (13) 2015 (12) 2016 (9) 2017 (9) 2018 (7) 2019 (5) (-) 2020 (10) 2021 (15) 2022 (14) 2023 (10) 2024 (2) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (8) Genetics and Genomics of Cardiovascular Diseases (1) Genome Diversification & Integrity (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) Mobile DNA (1) Molecular Immunology and Gene Therapy (1) Pluripotent Stem Cells (1) (-) Proteome Dynamics (8) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (4) RNA Biology and Posttranscriptional Regulation (1) Translational Tumorimmunology (1) 16 Results: Active Filter: Janz, Martin Dr.Prigione, Alessandro Prof. Dr.Selbach, Matthias Prof. Dr.Biology of Malignant LymphomasProteome Dynamics20062020 Sort: Result score Newest to oldest Oldest to newest May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken March 16, 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann December 01, 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann July 01, 2020 / Mol Cell Proteomics Peptide-based interaction proteomics K. Meyer M. Selbach March 18, 2020 / Nucleic Acids Res The human ZC3H3 and RBM26/27 proteins are critical for PAXT-mediated nuclear RNA decay T. Silla M. Schmid Y. Dou W. Garland M. Milek K. Imami D. Johnsen P. Polak J.S. Andersen M. Selbach M. Landthaler T. Jensen February 26, 2020 / Cell Syst Keeping the proportions of protein complex components in check J.C. Taggart H. Zauber M. Selbach G.W. Li E. McShane October 01, 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz Pagination Current page 1 Page 2 Next page Next › Last page Last »
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
March 16, 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann
December 01, 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann
March 18, 2020 / Nucleic Acids Res The human ZC3H3 and RBM26/27 proteins are critical for PAXT-mediated nuclear RNA decay T. Silla M. Schmid Y. Dou W. Garland M. Milek K. Imami D. Johnsen P. Polak J.S. Andersen M. Selbach M. Landthaler T. Jensen
February 26, 2020 / Cell Syst Keeping the proportions of protein complex components in check J.C. Taggart H. Zauber M. Selbach G.W. Li E. McShane
October 01, 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz